Literature DB >> 19345330

TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma.

Silvia Peñuelas1, Judit Anido, Rosa M Prieto-Sánchez, Gerard Folch, Ignasi Barba, Isabel Cuartas, David García-Dorado, M Antonia Poca, Juan Sahuquillo, Jose Baselga, Joan Seoane.   

Abstract

Glioma-initiating cells (GICs) are responsible for the initiation and recurrence of gliomas. Here, we identify a molecular mechanism that regulates the self-renewal capacity of patient-derived GICs. We show that TGF-beta and LIF induce the self-renewal capacity and prevent the differentiation of GICs. TGF-beta induces the self-renewal capacity of GICs, but not of normal human neuroprogenitors, through the Smad-dependent induction of LIF and the subsequent activation of the JAK-STAT pathway. The effect of TGF-beta and LIF on GICs promotes oncogenesis in vivo. Some human gliomas express high levels of LIF that correlate with high expression of TGF-beta2 and neuroprogenitor cell markers. Our results show that TGF-beta and LIF have an essential role in the regulation of GICs in human glioblastoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19345330     DOI: 10.1016/j.ccr.2009.02.011

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  214 in total

1.  STAT3 tyrosine phosphorylation influences survival in glioblastoma.

Authors:  Peter Birner; Kalina Toumangelova-Uzeir; Sevdalin Natchev; Marin Guentchev
Journal:  J Neurooncol       Date:  2010-05-09       Impact factor: 4.130

Review 2.  Potential therapeutic implications of cancer stem cells in glioblastoma.

Authors:  Lin Cheng; Shideng Bao; Jeremy N Rich
Journal:  Biochem Pharmacol       Date:  2010-05-10       Impact factor: 5.858

Review 3.  Cancer stem cell hypotheses: impact on modern molecular physiology and pharmacology research.

Authors:  Igor Pantic
Journal:  J Biosci       Date:  2011-12       Impact factor: 1.826

Review 4.  Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells.

Authors:  Gaoliang Ouyang; Zhe Wang; Xiaoguang Fang; Jia Liu; Chaoyong James Yang
Journal:  Cell Mol Life Sci       Date:  2010-03-18       Impact factor: 9.261

5.  Growth factor- and cytokine-driven pathways governing liver stemness and differentiation.

Authors:  Aránzazu Sánchez; Isabel Fabregat
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

6.  Engineering a potent receptor superagonist or antagonist from a novel IL-6 family cytokine ligand.

Authors:  Jun W Kim; Cesar P Marquez; R Andres Parra Sperberg; Jiaxiang Wu; Won G Bae; Po-Ssu Huang; E Alejandro Sweet-Cordero; Jennifer R Cochran
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-10       Impact factor: 11.205

7.  Chloroquine inhibits the malignant phenotype of glioblastoma partially by suppressing TGF-beta.

Authors:  Laurent-Olivier Roy; Marie-Belle Poirier; David Fortin
Journal:  Invest New Drugs       Date:  2015-08-15       Impact factor: 3.850

Review 8.  Cancer stem cells: a new framework for the design of tumor therapies.

Authors:  Boyan K Garvalov; Till Acker
Journal:  J Mol Med (Berl)       Date:  2010-10-02       Impact factor: 4.599

9.  Stem Cell Factor LIFted as a Promising Clinical Target for Cancer Therapy.

Authors:  Yu Shi; Sean Hunter; Tony Hunter
Journal:  Mol Cancer Ther       Date:  2019-08       Impact factor: 6.261

10.  Inflammation and Gliomagenesis: Bi-Directional Communication at Early and Late Stages of Tumor Progression.

Authors:  Rui Pedro Galvão; Hui Zong
Journal:  Curr Pathobiol Rep       Date:  2013-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.